Mustang Bio (MBIO) Revenue (2018)
Mustang Bio (MBIO) posted quarterly Revenue of $50000.0 for Q1 2018.
Mustang Bio (MBIO) Revenue (2018) Analysis & Trends
Mustang Bio (MBIO) has reported Revenue for 1 consecutive years, with $50000.0 the latest figure, recorded in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 674.14 Mn |
| 10 | Mustang Bio | 3.87 Mn | 3.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 50,000.00 |